Cargando…
A narrative review of chimeric antigen receptor-T (CAR-T) cell therapy for lung cancer
Lung cancer represents one of the most common and deadliest cancers in the world. Chimeric antigen receptor-T cell (CAR-T) therapy which can recognize antigens in a major histocompatibility complex (MHC)-independent manner provides a new approach for tumor treatment. However, lung cancer, as a solid...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AME Publishing Company
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8246176/ https://www.ncbi.nlm.nih.gov/pubmed/34268421 http://dx.doi.org/10.21037/atm-20-5419 |